Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DR-105 for Menstrually-Related Migraine
NCT00781456Phase 2Completed
- Sponsor
- Duramed Research
- Start
- Jan 2009
- Primary completion
- Aug 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in migraine comparing Seasonique with Placebo (2 arms). Primary endpoint: Percentage of Participants With >= 50% Reduction in Migraine Frequency During the Treatment Period. Started Jan 2009; status: completed.
02
Drugs
Seasonique
03
Conditions
migraine
Beyond the preview
Go deeper on NCT00781456.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00781456.